Project Number 5P50AG005134-27 Agency/Funding Organization NIA Funding Year 2010 View Full Project Details for THE ROLE OF ADVANCED CAA IN ALZHEIMER'S DEMENTIA Research Categorization Primary Disease / Condition Alzheimer's Disease Vascular Dementia/Dysfunction CADRO Category B. Diagnosis, Assessment, and Disease Monitoring 5. Re-Purposed Biomarkers d. White Matter Lesions/Damage Category F. Research Resources 1. Alzheimer's Disease Centers Researcher and Organization Principal Investigator VISWANATHAN, ANAND Principal Investigator First Name ANAND Principal Investigator Last Name VISWANATHAN Awardee Organization MASSACHUSETTS GENERAL HOSPITAL Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-AG-09-001: ALZHEIMER'S DISEASE RESEARCH CENTERS (P50) FY Overall Cost $155,402 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official PHELPS, CREIGHTON H. Related Resources Repository [NIAGADS] Transethnic GWAS Summary Statistics - Jun et al. (2017) [NIAGADS] ADC1- Alzheimer Disease Center Dataset 1 [NIAGADS] ADC2- Alzheimer Disease Center Dataset 2 [NIAGADS] ADC3- Alzheimer Disease Center Dataset 3 [NIAGADS] ADGC African American Summary Statistics- Reitz et al. (2013) [NIAGADS] ADGC Neuropath Summary Stats and Phenotypes- Beecham et al. (2014) [NIAGADS] ADGC Summary Statistics- Naj et al. (2011) Massachusetts General Hospital/Harvard Medical School Alzheimer's Disease Research Center National Alzheimer's Coordinating Center (NACC) [AlzPED] Methylene blue does not reverse existing neurofibrillary tangle pathology in the rTg4510 mouse model of tauopathy Pagination Page 1 Next page ››
